Teva Must Face Bulk Of Asthma Inhaler Antitrust Suit <https://www.law360.com/competition/articles/1834679?nl_pk=6416fd97-1dc4-4e02-b7d8-a89ca44ecaf4&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2024-05-09&read_main=1&nlsidx=0&nlaidx=2> By Bryan Koenig A Massachusetts federal judge largely refused Tuesday to toss antitrust claims accusing Teva of a decadelong anticompetitive scheme to delay generic competition for its blockbuster QVAR asthma inhalers, finding it plausible that Teva paid off a would-be rival and forcibly switched doctors and patients to a new product. Memorandum attached | Read full article » <https://www.law360.com/competition/articles/1834679?nl_pk=6416fd97-1dc4-4e02-b7d8-a89ca44ecaf4&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2024-05-09&read_more=1&nlsidx=0&nlaidx=2> | Save to favorites » <https://www.law360.com/competition/articles/1834679?nl_pk=6416fd97-1dc4-4e02-b7d8-a89ca44ecaf4&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2024-05-09&read_later=1&nlsidx=0&nlaidx=2>